Hong Kong Connect Flows: 11 Weeks of Inflows
Southbound connect recorded 11 weeks of consecutive inflows. We highlight Tencent and BYD that dominated the inflows last week.
485 Views
Guangzhou Baiyunshan Pharmaceutical Holdings (874.HK) - Conservative About the Outlook
This insight analyzed Baiyunshan’s 2021Q3 performance, the core business segments, the comparison with peers, the concerns on business transition,...
692 Views
Pre-IPO HTDK Medical Holdings - Policy Risk Is the Biggest Uncertainty
The article mainly analyzed HTDK Medical Holdings in terms of the industry characteristics, the potential policy risk, the business, the financial...
502 Views
Pre-IPO Guangzhou Pharmaceuticals - The Risk Points Gradually Emerged
As Guangzhou Pharmaceuticals submitted the IPO application, the risk points emerged considering the competition pattern, new policies and business...
491 Views
Initiating Coverage of CR Pharma With Narrow Moat Rating and HKD 13.20 FVE
We initiate coverage on China Resources Pharmaceutical (3320 HK) with a narrow moat rating and a fair value estimate of HKD 13.20 per share. This...
532 Views